MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a health professional report with the FDA on 2017-11-22 for COCHLEAR? VISTAFIX? VXI300 IMPLANT 3MM 93100 manufactured by Cochlear Bone Anchored Solutions Ab.
[92831279]
This report is submitted (b)(6) 2017, by (b)(4).
Patient Sequence No: 1, Text Type: N, H10
[92831280]
Per the clinic, the patient experienced skin overgrowth at abutment site; subsequently the patient was placed under general anesthesia and underwent skin revision surgery during an abutment change. The implanted device remains.
Patient Sequence No: 1, Text Type: D, B5
Report Number | 6000034-2017-02167 |
MDR Report Key | 7055068 |
Report Source | HEALTH PROFESSIONAL |
Date Received | 2017-11-22 |
Date of Report | 2017-11-16 |
Date Mfgr Received | 2017-11-16 |
Date Added to Maude | 2017-11-22 |
Event Key | 0 |
Report Source Code | Manufacturer report |
Manufacturer Link | Y |
Number of Patients in Event | 0 |
Adverse Event Flag | 3 |
Product Problem Flag | 3 |
Reprocessed and Reused Flag | 3 |
Health Professional | 3 |
Initial Report to FDA | 3 |
Report to FDA | 3 |
Event Location | 3 |
Manufacturer Contact | MS. KRISTEL KOHNE |
Manufacturer Street | 1 UNIVERSITY AVENUE |
Manufacturer City | MACQUARIE UNIVERSITY, NSW 2109, |
Manufacturer Country | AS |
Manufacturer Postal | 2109, |
Single Use | 3 |
Previous Use Code | 3 |
Event Type | 3 |
Type of Report | 3 |
Brand Name | COCHLEAR? VISTAFIX? VXI300 IMPLANT 3MM |
Generic Name | COCHLEAR BAHA VISTAFIX SYSTEM |
Product Code | FZE |
Date Received | 2017-11-22 |
Model Number | 93100 |
Catalog Number | 93100 |
Lot Number | 98609 |
Operator | LAY USER/PATIENT |
Device Availability | N |
Device Eval'ed by Mfgr | R |
Device Sequence No | 1 |
Device Event Key | 0 |
Manufacturer | COCHLEAR BONE ANCHORED SOLUTIONS AB |
Manufacturer Address | KONSTRUKTIONSV?GEN 14 PO BOX 82 M?LNLYCKE, 435 22 SW 435 22 |
Patient Number | Treatment | Outcome | Date |
---|---|---|---|
1 | 0 | 1. Required No Informationntervention | 2017-11-22 |